BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10723109)

  • 1. Linkage analysis of 150 high-risk prostate cancer families at 1q24-25.
    Goode EL; Stanford JL; Chakrabarti L; Gibbs M; Kolb S; McIndoe RA; Buckley VA; Schuster EF; Neal CL; Miller EL; Brandzel S; Hood L; Ostrander EA; Jarvik GP
    Genet Epidemiol; 2000 Mar; 18(3):251-75. PubMed ID: 10723109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics.
    Xu J
    Am J Hum Genet; 2000 Mar; 66(3):945-57. PubMed ID: 10712209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study.
    Cooney KA; McCarthy JD; Lange E; Huang L; Miesfeldt S; Montie JE; Oesterling JE; Sandler HM; Lange K
    J Natl Cancer Inst; 1997 Jul; 89(13):955-9. PubMed ID: 9214675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer.
    Berry R; Schaid DJ; Smith JR; French AJ; Schroeder JJ; McDonnell SK; Peterson BJ; Wang ZY; Carpten JD; Roberts SG; Tester DJ; Blute ML; Trent JM; Thibodeau SN
    Am J Hum Genet; 2000 Feb; 66(2):539-46. PubMed ID: 10677314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Swedish families with hereditary prostate cancer, linkage to the HPC1 locus on chromosome 1q24-25 is restricted to families with early-onset prostate cancer.
    Grönberg H; Smith J; Emanuelsson M; Jonsson BA; Bergh A; Carpten J; Isaacs W; Xu J; Meyers D; Trent J; Damber JE
    Am J Hum Genet; 1999 Jul; 65(1):134-40. PubMed ID: 10364525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25.
    McIndoe RA; Stanford JL; Gibbs M; Jarvik GP; Brandzel S; Neal CL; Li S; Gammack JT; Gay AA; Goode EL; Hood L; Ostrander EA
    Am J Hum Genet; 1997 Aug; 61(2):347-53. PubMed ID: 9311739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1.
    Grönberg H; Xu J; Smith JR; Carpten JD; Isaacs SD; Freije D; Bova GS; Danber JE; Bergh A; Walsh PC; Collins FS; Trent JM; Meyers DA; Isaacs WB
    Cancer Res; 1997 Nov; 57(21):4707-9. PubMed ID: 9354426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCAP is the major known prostate cancer predisposing locus in families from south and west Europe.
    Cancel-Tassin G; Latil A; Valéri A; Mangin P; Fournier G; Berthon P; Cussenot O
    Eur J Hum Genet; 2001 Feb; 9(2):135-42. PubMed ID: 11313747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease.
    Schleutker J; Matikainen M; Smith J; Koivisto P; Baffoe-Bonnie A; Kainu T; Gillanders E; Sankila R; Pukkala E; Carpten J; Stephan D; Tammela T; Brownstein M; Bailey-Wilson J; Trent J; Kallioniemi OP
    Clin Cancer Res; 2000 Dec; 6(12):4810-5. PubMed ID: 11156239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of chromosome 1q42.2-43 in 152 families with high risk of prostate cancer.
    Gibbs M; Chakrabarti L; Stanford JL; Goode EL; Kolb S; Schuster EF; Buckley VA; Shook M; Hood L; Jarvik GP; Ostrander EA
    Am J Hum Genet; 1999 Apr; 64(4):1087-95. PubMed ID: 10090894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of prostate cancer in an analysis of linkage to four putative susceptibility loci.
    Goode EL; Stanford JL; Peters MA; Janer M; Gibbs M; Kolb S; Badzioch MD; Hood L; Ostrander EA; Jarvik GP
    Clin Cancer Res; 2001 Sep; 7(9):2739-49. PubMed ID: 11555587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linkage of prostate cancer susceptibility loci to chromosome 1.
    Xu J; Zheng SL; Chang B; Smith JR; Carpten JD; Stine OC; Isaacs SD; Wiley KE; Henning L; Ewing C; Bujnovszky P; Bleeker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB
    Hum Genet; 2001 Apr; 108(4):335-45. PubMed ID: 11379880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci.
    Brown WM; Lange EM; Chen H; Zheng SL; Chang B; Wiley KE; Isaacs SD; Walsh PC; Isaacs WB; Xu J; Cooney KA
    Br J Cancer; 2004 Jan; 90(2):510-4. PubMed ID: 14735201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus.
    Grönberg H; Isaacs SD; Smith JR; Carpten JD; Bova GS; Freije D; Xu J; Meyers DA; Collins FS; Trent JM; Walsh PC; Isaacs WB
    JAMA; 1997 Oct; 278(15):1251-5. PubMed ID: 9333266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of HPC1, HPCX, and PCaP in Icelandic hereditary prostate cancer.
    Bergthorsson JT; Johannesdottir G; Arason A; Benediktsdottir KR; Agnarsson BA; Bailey-Wilson JE; Gillanders E; Smith J; Trent J; Barkardottir RB
    Hum Genet; 2000 Oct; 107(4):372-5. PubMed ID: 11129338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low frequency of allelic imbalance at the prostate cancer susceptibility loci HPC1 and 1p36 in Swedish men with hereditary prostate cancer.
    Ahman AK; Jonsson BA; Damber JE; Bergh A; Emanuelsson M; Grönberg H
    Genes Chromosomes Cancer; 2000 Dec; 29(4):292-6. PubMed ID: 11066072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4.
    Goddard KA; Witte JS; Suarez BK; Catalona WJ; Olson JM
    Am J Hum Genet; 2001 May; 68(5):1197-206. PubMed ID: 11309685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Confirmation of prostate cancer susceptibility genes using high-risk families.
    Jarvik GP; Stanford JL; Goode EL; McIndoe R; Kolb S; Gibbs M; Hood L; Ostrander EA
    J Natl Cancer Inst Monogr; 1999; (26):81-7. PubMed ID: 10854490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression models for linkage heterogeneity applied to familial prostate cancer.
    Schaid DJ; McDonnell SK; Thibodeau SN
    Am J Hum Genet; 2001 May; 68(5):1189-96. PubMed ID: 11309684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1. CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate Group.
    Dunsmuir WD; Edwards SM; Lakhani SR; Young M; Corbishley C; Kirby RS; Dearnaley DP; Dowe A; Ardern-Jones A; Kelly J; Eeles RA
    Br J Cancer; 1998 Dec; 78(11):1430-3. PubMed ID: 9836474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.